Physician profile
Edward A Luce
NPI 1487611000
$1,919.30
in general payments reported to CMS, 2019-2025
12 companies · $591 in 2025
The $591 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $324 · 2022: $204 · 2023: $109 · 2024: $691 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,391.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $504.27 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Smith+Nephew, INC. | $248.70 | 2024-2025 | Stravix, Grafix Pl |
| Allergan, INC. | $193.62 | 2019 | |
| Kci USA, INC. | $172.14 | 2022-2023 | Prevena, V.A.C. Dermatac, V.A.C. Veraflo |
| Axogen | $141.25 | 2022 | |
| Abbvie INC. | $125.10 | 2025 | |
| Kerecis Limited | $121.32 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Depuy Synthes Sales INC. | $106.76 | 2024 | Trumatch |
| Medline Industries LP | $106.02 | 2019 | |
| Mentor Worldwide LLC | $105.08 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Musculoskeletal Transplant Foundation INC. | $70.50 | 2025 | |
| Misonix INC | $24.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Luce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.